WO2003033656A3 - Proteines msrebp utilisees comme modificateurs de la voie srebp et leurs methodes d'utilisation - Google Patents
Proteines msrebp utilisees comme modificateurs de la voie srebp et leurs methodes d'utilisation Download PDFInfo
- Publication number
- WO2003033656A3 WO2003033656A3 PCT/US2002/032807 US0232807W WO03033656A3 WO 2003033656 A3 WO2003033656 A3 WO 2003033656A3 US 0232807 W US0232807 W US 0232807W WO 03033656 A3 WO03033656 A3 WO 03033656A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- srebp pathway
- msrebps
- modifiers
- msrebp
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002332130A AU2002332130A1 (en) | 2001-10-16 | 2002-10-15 | Msrebps as modifiers of the srebp pathway and methods of use |
Applications Claiming Priority (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32989001P | 2001-10-16 | 2001-10-16 | |
US60/329,890 | 2001-10-16 | ||
US34228701P | 2001-12-21 | 2001-12-21 | |
US34228801P | 2001-12-21 | 2001-12-21 | |
US60/342,288 | 2001-12-21 | ||
US60/342,287 | 2001-12-21 | ||
US34809602P | 2002-01-14 | 2002-01-14 | |
US60/348,096 | 2002-01-14 | ||
US35140102P | 2002-01-25 | 2002-01-25 | |
US35136102P | 2002-01-25 | 2002-01-25 | |
US35140302P | 2002-01-25 | 2002-01-25 | |
US60/351,401 | 2002-01-25 | ||
US60/351,403 | 2002-01-25 | ||
US60/351,361 | 2002-01-25 | ||
US35882602P | 2002-02-21 | 2002-02-21 | |
US60/358,826 | 2002-02-21 | ||
US36861502P | 2002-03-27 | 2002-03-27 | |
US60/368,615 | 2002-03-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003033656A2 WO2003033656A2 (fr) | 2003-04-24 |
WO2003033656A3 true WO2003033656A3 (fr) | 2003-11-06 |
Family
ID=27578812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/032807 WO2003033656A2 (fr) | 2001-10-16 | 2002-10-15 | Proteines msrebp utilisees comme modificateurs de la voie srebp et leurs methodes d'utilisation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002332130A1 (fr) |
WO (1) | WO2003033656A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2012355356B2 (en) | 2011-12-22 | 2017-10-12 | Genentech, Inc. | Ion exchange membrane chromatography |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891631A (en) * | 1993-05-13 | 1999-04-06 | Board Of Regents, The University Of Texas System | Methods relating tosterol regulatory element binding proteins |
US6322962B1 (en) * | 1998-08-14 | 2001-11-27 | Board Of Regents, The University Of Texas System | Sterol-regulated Site-1 protease and assays of modulators thereof |
-
2002
- 2002-10-15 WO PCT/US2002/032807 patent/WO2003033656A2/fr not_active Application Discontinuation
- 2002-10-15 AU AU2002332130A patent/AU2002332130A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891631A (en) * | 1993-05-13 | 1999-04-06 | Board Of Regents, The University Of Texas System | Methods relating tosterol regulatory element binding proteins |
US6322962B1 (en) * | 1998-08-14 | 2001-11-27 | Board Of Regents, The University Of Texas System | Sterol-regulated Site-1 protease and assays of modulators thereof |
Also Published As
Publication number | Publication date |
---|---|
AU2002332130A1 (en) | 2003-04-28 |
WO2003033656A2 (fr) | 2003-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002099138A3 (fr) | Hs2sts utilises comme modificateurs de la voie p53 et methodes d'utilisation associees | |
WO2002098356A3 (fr) | Genes de ppp2c en tant que modificateurs de la voie p53 et methodes d'utilisation | |
WO2003074674A3 (fr) | Genes msra utilises en tant que modificateurs de la voie p53 et procedes d'utilisation associes | |
WO2003014301A3 (fr) | Hprp4 en tant que modificateurs de la voie de passage p53 leurs et methodes d'utilisation | |
WO2002055663A3 (fr) | Modulation du passage srebp par des hisrs cibles | |
WO2002099068A3 (fr) | Lce utilises comme modificateurs de la voie p53 et procede d'utilisation | |
WO2003006614A3 (fr) | Ube2 en tant qu'agents de modification du passage p21 et procedes permettant leur utilisation | |
WO2005016287A3 (fr) | Prkwnk utilises en tant que modificateurs de la voie rac et methodes d'utilisation associees | |
WO2003051905A3 (fr) | Taojik utilises en tant que modificateurs de la voie beta-catenine et procedes d'utilisation associes | |
WO2002099043A3 (fr) | P5crs identifies comme des modificateurs de la voie p53 et procedes d'utilisation | |
WO2003035831A3 (fr) | Lrrcaps en tant que modificateurs de la voie de passage p53 et leurs procedes d'utilisation | |
WO2003033656A3 (fr) | Proteines msrebp utilisees comme modificateurs de la voie srebp et leurs methodes d'utilisation | |
WO2004014301A3 (fr) | Genes psmc utilises comme modificateurs du trajet retiniblastome (rb) et techniques d'utilisation | |
WO2004048538A3 (fr) | Caseine kinases modifiant la voie rac et leurs procedes d'utilisation | |
WO2003045314A3 (fr) | Mhyps comme modificateurs de morphogenese de ramification et procedes d'utilisation | |
WO2005017123A3 (fr) | Mptens utilises comme modificateurs de la voie pten et procedes d'utilisation | |
WO2003052068A3 (fr) | Genes mbcat agissant comme modificateurs du mecanisme d'action de la beta-catenine et methodes d'utilisation | |
WO2004048541A3 (fr) | Cct6 utilises comme modificateurs de la voie rb, et procedes d'utilisation correspondants | |
WO2003066811A3 (fr) | Genes msrebp utilises en tant que modificateurs de la voie des proteines srebp, et procedes d'utilisation associes | |
WO2003074673A3 (fr) | Lgals tenant lieu de modificateurs de la voie de chk et leurs procedes d'utilisation | |
WO2003074677A3 (fr) | Mchk comme modulateurs du mecanisme d'action de chk et procedes d'utilisation | |
WO2003052066A3 (fr) | Klcs utilises en tant que genes modificateurs de la voie p53 et procedes d'utilisation correspondant | |
WO2003052070A3 (fr) | Genes vps41 en tant que modificateurs de la mort cellulaire et procedes d'utilisation associe | |
WO2004104168A3 (fr) | Mrb utilises comme modificateurs de la voie des rb et procedes d'utilisation correspondants | |
WO2004024881A3 (fr) | Ldlr utilise en tant que modificateur de la voie p53 et procedes d'utilisation associes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |